Archive

Our CEO, Dr Chris Barber reflects on a successful 12 months for Lhasa and discusses our plans for the year ahead.

A key requirement of ICH M7 is to use two complementary (Q)SAR methodologies, one expert rule-based and the second statistical-based. This blog article recognises the benefits provided when in silico systems are integrated to provide a full ICH M7 assessment in one environment.

Discover how Lhasa Limited can help make mutagenicity assessment a simpler task, in this article!

The world of work is changing. My goodness is that an understatement! Never have I truly felt that we are working in what is described as a VUCA (volatile, uncertain, complex and ambiguous) world as much as I do right now.

The global pandemic has undoubtedly had a huge impact on many companies in 2020, Lhasa is no exception.

Building software and providing services that meet the needs of the user was central to the unique way in which Lhasa was founded and is still very much at the core of how we operate.

The creation of great software cannot be achieved using a single pre-determined set of rules, if it could, everyone would follow those rules and it would be straightforward. 

There is no perfect formula when it comes to trying to organise any kind of work trip. Normally, you have to engage through a series of mental gymnastics to try and balance semi-quantifiable concepts such as ‘return on investment’ and ‘value’.

Let’s take ‘value’ for instance. Is the value of the trip based on a new sale? The time spent out of the office? Establishing a personal contact to secure existing business? Ensuring that the product that you’re supporting is used and understood to the maximum capacity?

Now balance that with travelling halfway across the planet, rather than a quick hop on the Eurostar.

Read more about our trip to India earlier this year.